Retaglutide is a innovative GLP-1 receptor agonist currently under research for the treatment of type 2 diabetes. This medication works by enhancing the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://zoepjak644408.creacionblog.com/38857092/retaglutide-a-promising-glp-1-receptor-agonist